Forward Pharma FA ApS: Financial statements 2022
CVR: 37281603
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Forward Pharma FA ApS (CVR 37281603) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -32,125 and a net result of DKK -35,837 compared with DKK -11,447 the year before. Equity in the 2022 report amounted to DKK 39,283. The solvency ratio was 5.9%.
- Gross Profit
- DKK -32,125
- Profit/Loss
- DKK -35,837
- Equity
- DKK 39,283
- Total Assets
- DKK 666,311
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -32 t. | -36 t. | 39 t. | - |
| 2021 | - | -8 t. | -11 t. | 75 t. | - |
| 2020 | - | -19 t. | -23 t. | 87 t. | - |
| 2019 | - | -31 t. | -34 t. | 10 t. | - |
| 2018 | - | -25 t. | -28 t. | -56 t. | - |
Keep an eye on Forward Pharma FA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Forward Pharma FA ApS has published its annual report for 2021. Gross profit came to DKK -8,250, and the net result was DKK -11,447.
About Forward Pharma FA ApS
Forward Pharma FA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2015. The company has been dissolved on 27 October 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2022, the company reported a gross profit of DKK -32,125 and a net result of DKK -35,837 compared with DKK -11,447 the year before. Equity in the 2022 report amounted to DKK 39,283.